| No images? Click here  Wednesday, 03 September 2025 Embargoed until 15.00 CEST / 13.00 GMT on 5 September 2025 NOTE TO JOURNALISTS Release of the WHO updated Model Lists of Essential Medicines (and new embargo time) On 5 September 2025, the World Health Organization (WHO) will release the updated editions of its Model Lists of Essential Medicines (EML) and Essential Medicines for Children (EMLc), to include key cancer and diabetes treatments, among others. The revisions mark the 24th edition of WHO EML and the 10th edition of EMLc. WHO Model Lists include medicines for the priority health needs of populations. They are adopted in over 150 countries, serving as a basis for public sector procurement, supply of medicines, and health insurance and reimbursement schemes. Essential medicines are selected with due regard to disease prevalence and public health relevance, evidence of efficacy and safety, and comparative cost-effectiveness. They are intended to always be available in functioning health systems, in appropriate dosage forms, of assured quality and at prices individuals and health systems can afford. The press kit is available to journalists under embargo. It contains the press release, EML and EMLc, the report of the 25th WHO Expert Committee on the Selection and Use of Essential Medicines (executive summary), and the 2025 AWaRe classification of antibiotics (Access, Watch and Reserve). To obtain a copy or to request an interview with the WHO experts, please write to smailbegovica@who.int with a copy to mediainquiries@who.int. The information in this Note and in the press kit is embargoed until 15.00 CEST / 13.00 GMT on 5 September 2025.  Media contacts:  You are receiving this NO-REPLY email because you are included on a WHO mail list.  |
Wednesday, September 3, 2025
NOTE TO JOURNALISTS: Release of the WHO Essential Medicines Lists
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment